Paraneoplastic Glomerulopathies: Mechanistic and Pathogenic Insights Available to Purchase

2.

Izzedine

H

,

Perazella

MA

.

Anticancer drug-induced acute kidney injury

.

Kidney Int Rep

.

2017

;

2

(

4

):

504

–

14

.

3.

Ronco

PM

.

Paraneoplastic glomerulopathies: new insights into an old entity

.

Kidney Int

.

1999

;

56

(

1

):

355

–

77

.

4.

Galloway

J

.

Remarks ON HODGKIN'S disease

.

Br Med J

.

1922

;

2

(

3234

):

1201

–

8.2

.

5.

Chong

WH

,

Molinolo

AA

,

Chen

CC

,

Collins

MT

.

Tumor-induced osteomalacia

.

Endocr Relat Cancer

.

2011

;

18

(

3

):

R53

–

77

.

6.

Rajkumar

SV

,

Dimopoulos

MA

,

Palumbo

A

,

Blade

J

,

Merlini

G

,

Mateos

MV

, et al.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

.

Lancet Oncol

.

2014

;

15

(

12

):

e538

–

48

.

7.

Pamuk

GE

,

Demir

M

,

Orüm

H

,

Turgut

B

,

Ozyilmaz

F

,

Tekgündüz

E

.

Secondary amyloidosis causing nephrotic syndrome in a patient with non-Hodgkin's lymphoma: quite a rare diagnosis

.

Clin Lab Haematol

.

2006

;

28

(

4

):

259

–

61

.

8.

Leung

N

,

Bridoux

F

,

Hutchison

CA

,

Nasr

SH

,

Cockwell

P

,

Fermand

JP

, et al.

Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant

.

Blood

.

2012

;

120

(

22

):

4292

–

5

.

9.

Lien

YH

,

Lai

LW

.

Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis

.

Nat Rev Nephrol

.

2011

;

7

(

2

):

85

–

95

.

10.

Muthukumaran

A

,

Wanchoo

R

,

Seshan

SV

,

Gudsoorkar

P

.

Paraneoplastic glomerular diseases

.

Adv Kidney Dis Health

.

2024

;

31

(

4

):

346

–

57

.

11.

Birkeland

SA

,

Storm

HH

.

Glomerulonephritis and malignancy: a population-based analysis

.

Kidney Int

.

2003

;

63

(

2

):

716

–

21

.

12.

Zeng

CH

,

Chen

HM

,

Wang

RS

,

Chen

Y

,

Zhang

SH

,

Liu

L

, et al.

Etiology and clinical characteristics of membranous nephropathy in Chinese patients

.

Am J Kidney Dis

.

2008

;

52

(

4

):

691

–

8

.

13.

Lefaucheur

C

,

Stengel

B

,

Nochy

D

,

Martel

P

,

Hill

GS

,

Jacquot

C

, et al.

Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association

.

Kidney Int

.

2006

;

70

(

8

):

1510

–

7

.

14.

Bjørneklett

R

,

Vikse

BE

,

Svarstad

E

,

Aasarød

K

,

Bostad

L

,

Langmark

F

, et al.

Long-term risk of cancer in membranous nephropathy patients

.

Am J Kidney Dis

.

2007

;

50

(

3

):

396

–

403

.

15.

Smith

RA

,

Andrews

KS

,

Brooks

D

,

Fedewa

SA

,

Manassaram-Baptiste

D

,

Saslow

D

, et al.

Cancer screening in the United States, 2018: a review of current American cancer society guidelines and current issues in cancer screening

.

CA Cancer J Clin

.

2018

;

68

(

4

):

297

–

316

.

16.

Lee

JC

,

Yamauchi

H

,

Hopper

J

Jr.

The association of cancer and the nephrotic syndrome

.

Ann Intern Med

.

1966

;

64

(

1

):

41

–

51

.

17.

Couser

WG

.

Primary membranous nephropathy

.

Clin J Am Soc Nephrol

.

2017

;

12

(

6

):

983

–

97

.

18.

Beck

LH

Jr.,

Bonegio

RG

,

Lambeau

G

,

Beck

DM

,

Powell

DW

,

Cummins

TD

, et al.

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

.

N Engl J Med

.

2009

;

361

(

1

):

11

–

21

.

19.

Tomas

NM

,

Beck

LH

Jr.,

Meyer-Schwesinger

C

,

Seitz-Polski

B

,

Ma

H

,

Zahner

G

, et al.

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy

.

N Engl J Med

.

2014

;

371

(

24

):

2277

–

87

.

20.

Sethi

S

,

Debiec

H

,

Madden

B

,

Charlesworth

MC

,

Morelle

J

,

Gross

L

, et al.

Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

.

Kidney Int

.

2020

;

97

(

1

):

163

–

74

.

21.

Leeaphorn

N

,

Kue-A-Pai

P

,

Thamcharoen

N

,

Ungprasert

P

,

Stokes

MB

,

Knight

EL

.

Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies

.

Am J Nephrol

.

2014

;

40

(

1

):

29

–

35

.

22.

Zaghrini

C

,

Seitz-Polski

B

,

Justino

J

,

Dolla

G

,

Payré

C

,

Jourde-Chiche

N

, et al.

Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy

.

Kidney Int

.

2019

;

95

(

3

):

666

–

79

.

23.

Xian

L

,

Dong

D

,

Luo

J

,

Zhuo

L

,

Li

K

,

Zhang

P

, et al.

Expression of THSD7A in neoplasm tissues and its relationship with proteinuria

.

BMC Nephrol

.

2019

;

20

(

1

):

332

.

24.

Taguchi

S

,

Koshikawa

Y

,

Ohyama

S

,

Miyachi

H

,

Ozawa

H

,

Asada

H

.

Thrombospondin type-1 domain-containing 7A-associated membranous nephropathy after resection of rectal cancer: a case report

.

BMC Nephrol

.

2019

;

20

(

1

):

43

.

25.

Caza

TN

,

Hassen

SI

,

Dvanajscak

Z

,

Kuperman

M

,

Edmondson

R

,

Herzog

C

, et al.

NELL1 is a target antigen in malignancy-associated membranous nephropathy

.

Kidney Int

.

2021

;

99

(

4

):

967

–

76

.

26.

Sethi

S

.

The many faces of NELL1 MN

.

Clin Kidney J

.

2023

;

16

(

3

):

442

–

6

.

27.

Kudose

S

,

Santoriello

D

,

Debiec

H

,

Canetta

PA

,

Bomback

AS

,

Stokes

MB

, et al.

The clinicopathologic spectrum of segmental membranous glomerulopathy

.

Kidney Int

.

2021

;

99

(

1

):

247

–

55

.

28.

Sethi

S

,

Beck

LH

Jr.,

Glassock

RJ

,

Haas

M

,

De Vriese

AS

,

Caza

TN

, et al.

Mayo clinic consensus report on membranous nephropathy: proposal for a novel classification

.

Mayo Clin Proc

.

2023

;

98

(

11

):

1671

–

84

.

29.

Larsen

CP

,

Messias

NC

,

Silva

FG

,

Messias

E

,

Walker

PD

.

Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies

.

Mod Pathol

.

2013

;

26

(

5

):

709

–

15

.

30.

Radice

A

,

Pieruzzi

F

,

Trezzi

B

,

Ghiggeri

G

,

Napodano

P

,

D'Amico

M

, et al.

Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases

.

J Nephrol

.

2018

;

31

(

2

):

271

–

8

.

31.

Baker

LW

,

Jimenez-Lopez

J

,

Geiger

XJ

,

Aslam

N

.

Malignancy-associated membranous nephropathy with positive anti-pla2r autoantibodies: coincidence or connection

.

Case Rep Nephrol Dial

.

2021

;

11

(

3

):

334

–

9

.

32.

Ai

S

,

Yan

X

,

Zhao

X

,

Ye

W

,

Wen

Y

,

Wang

J

, et al.

Malignancy-associated membranous nephropathy: focus on diagnosis and treatment

.

J Nephrol

.

2023

;

36

(

8

):

2355

–

63

.

33.

Hoxha

E

,

Beck

LH

Jr.,

Wiech

T

,

Tomas

NM

,

Probst

C

,

Mindorf

S

, et al.

An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy

.

J Am Soc Nephrol

.

2017

;

28

(

2

):

520

–

31

.

34.

Hoxha

E

,

Wiech

T

,

Stahl

PR

,

Zahner

G

,

Tomas

NM

,

Meyer-Schwesinger

C

, et al.

A mechanism for cancer-associated membranous nephropathy

.

N Engl J Med

.

2016

;

374

(

20

):

1995

–

6

.

35.

Beck

LH

Jr.

Membranous nephropathy and malignancy

.

Semin Nephrol

.

2010

;

30

(

6

):

635

–

44

.

36.

Ohtani

H

,

Wakui

H

,

Komatsuda

A

,

Okuyama

S

,

Masai

R

,

Maki

N

, et al.

Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy

.

Nephrol Dial Transpl

.

2004

;

19

(

3

):

574

–

9

.

37.

Vrana

JA

,

Theis

JD

,

Wegwerth

PJ

,

Dasari

S

,

Madden

B

,

Nasr

SH

, et al.

A reliable clinical test for detection of membranous nephropathy antigens using laser microdissection and mass spectrometry

.

Kidney Int

.

2024

;

106

(

5

):

907

–

12

.

38.

Liu

S

,

Wan

Y

,

Hu

Z

,

Wang

Z

,

Liu

F

.

Nephrotic syndrome associated with solid malignancies: a systematic review

.

BMC Nephrol

.

2024

;

25

(

1

):

215

.

39.

Moulin

B

,

Chantrel

F

,

Petitjean

P

,

Ronco

PM

.

Glomerular-lesions in chronic lymphoproliferative disorders

.

J Nephrol

.

1995

;

8

(

1

):

20

–

6

.

40.

Kofman

T

,

Zhang

SY

,

Copie-Bergman

C

,

Moktefi

A

,

Raimbourg

Q

,

Francois

H

, et al.

Minimal change nephrotic syndrome associated with non-Hodgkin lymphoid disorders: a retrospective study of 18 cases

.

Medicine (Baltim)

.

2014

;

93

(

24

):

350

–

8

.

41.

Hindocha

S

,

Gopaluni

S

,

Collins

GP

,

Shenbagaraman

P

.

Focal segmental glomerulosclerosis in a patient with mantle cell lymphoma

.

BMJ Case Rep

.

2015

;

2015

:

bcr2015211765

.

42.

Karakus

V

,

Atas

U

,

Uzuntas

S

,

Dere

Y

,

Meteoglu

I

.

A rare nephrotic syndrome related to chronic lymphocytic leukemia: focal segmental glomerulosclerosis

.

Cureus

.

2022

;

14

(

11

):

e31545

.

43.

Audard

V

,

Larousserie

F

,

Grimbert

P

,

Abtahi

M

,

Sotto

JJ

,

Delmer

A

, et al.

Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature

.

Kidney Int

.

2006

;

69

(

12

):

2251

–

60

.

44.

Nakayama

S

,

Yokote

T

,

Kobayashi

K

,

Hirata

Y

,

Akioka

T

,

Hiraoka

N

, et al.

Minimal-change nephrotic syndrome preceding Hodgkin lymphoma by 5 years with expression of tumor necrosis factor alpha in Hodgkin-Reed-Sternberg cells

.

Hum Pathol

.

2010

;

41

(

8

):

1196

–

9

.

45.

Audard

V

,

Zhang

SY

,

Copie-Bergman

C

,

Rucker-Martin

C

,

Ory

V

,

Candelier

M

, et al.

Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes

.

Blood

.

2010

;

115

(

18

):

3756

–

62

.

46.

Karras

A

,

de Montpreville

V

,

Fakhouri

F

,

Grünfeld

JP

,

Lesavre

P

;

Groupe d'Etudes des Néphropathies Associées aux Thymomes

.

Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature

.

Nephrol Dial Transpl

.

2005

;

20

(

6

):

1075

–

82

.

47.

Cheson

BD

,

Fisher

RI

,

Barrington

SF

,

Cavalli

F

,

Schwartz

LH

,

Zucca

E

, et al.

Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-hodgkin lymphoma: the lugano classification

.

J Clin Oncol

.

2014

;

32

(

27

):

3059

–

68

.

48.

Bergmann

J

,

Buchheidt

D

,

Waldherr

R

,

Maywald

O

,

van der Woude

FJ

,

Hehlmann

R

, et al.

IgA nephropathy and hodgkin's disease: a rare coincidence. Case report and literature review

.

Am J Kidney Dis

.

2005

;

45

(

1

):

e16

–

9

.

49.

Mustonen

J

,

Pasternack

A

,

Helin

H

.

IgA mesangial nephropathy in neoplastic diseases

.

Contrib Nephrol

.

1984

;

40

:

283

–

91

.

50.

Ramirez

G

,

Stinson

JB

,

Zawada

ET

,

Moatamed

F

.

IgA nephritis associated with mycosis fungoides. Report of two cases

.

Arch Intern Med

.

1981

;

141

(

10

):

1287

–

91

.

51.

Wilson

FP

,

Nasr

SH

,

Markowitz

GS

,

Naylor

EC

,

Sterman

PL

,

D'Agati

VD

.

A destructive nasal lesion and glomerulonephritis

.

Kidney Int

.

2006

;

69

(

9

):

1699

–

703

.

52.

Ng

MSY

,

Francis

L

,

Pillai

E

,

Mallett

AJ

.

Paraneoplastic immunoglobulin A nephropathy and associated focal segmental glomerulosclerosis in asymptomatic low volume B-cell lymphoma - a case report

.

BMC Nephrol

.

2018

;

19

(

1

):

224

.

53.

Magyarlaki

T

,

Kiss

B

,

Buzogány

I

,

Fazekas

A

,

Sükösd

F

,

Nagy

J

.

Renal cell carcinoma and paraneoplastic IgA nephropathy

.

Nephron

.

1999

;

82

(

2

):

127

–

30

.

54.

Talpur

R

,

Lifshitz

O

,

Breuer-Mcham

J

,

Duvic

M

.

Increased serum immunoglobulin levels are common in mycosis fungoides and Sézary syndrome

.

J Am Acad Dermatol

.

2002

;

47

(

5

):

685

–

91

.

55.

Taira

S

,

Kawagoe

M

,

Anzai

H

,

Yasukawa

M

,

Asakawa

S

,

Arai

S

, et al.

Immunoglobulin A-dominant membranoproliferative glomerulonephritis-like pattern of injury as a possible paraneoplastic nephropathy in a breast cancer patient

.

CEN Case Rep

.

2025

;

14

(

2

):

217

–

23

.

56.

Mitsui

H

,

Shibagaki

N

,

Kawamura

T

,

Matsue

H

,

Shimada

S

.

A clinical study of Henoch-Schönlein Purpura associated with malignancy

.

J Eur Acad Dermatol Venereol

.

2009

;

23

(

4

):

394

–

401

.

57.

Pertuiset

E

,

Liote

F

,

Launay-Russ

E

,

Kemiche

F

,

Cerf-Payrastre

I

,

Chesneau

AM

.

Adult Henoch-Schonlein purpura associated with malignancy

.

Semin Arthritis Rheum

.

2000

;

29

(

6

):

360

–

7

.

58.

Podjasek

JO

,

Wetter

DA

,

Pittelkow

MR

,

Wada

DA

.

Henoch-Schönlein purpura associated with solid-organ malignancies: three case reports and a literature review

.

Acta Derm Venereol

.

2012

;

92

(

4

):

388

–

92

.

59.

Izzedine

H

,

Perazella

MA

.

Thrombotic microangiopathy, cancer, and cancer drugs

.

Am J Kidney Dis

.

2015

;

66

(

5

):

857

–

68

.

60.

Aklilu

AM

,

Shirali

AC

.

Chemotherapy-associated thrombotic microangiopathy

.

Kidney360

.

2023

;

4

(

3

):

409

–

22

.

61.

Ravindran

A

,

Go

RS

,

Fervenza

FC

,

Sethi

S

.

Thrombotic microangiopathy associated with monoclonal gammopathy

.

Kidney Int

.

2017

;

91

(

3

):

691

–

8

.

62.

Martins

M

,

Bridoux

F

,

Goujon

JM

,

Meuleman

MS

,

Ribes

D

,

Rondeau

E

, et al.

Complement activation and thrombotic microangiopathy associated with monoclonal gammopathy: a national French case series

.

Am J Kidney Dis

.

2022

;

80

(

3

):

341

–

52

.

63.

Yui

JC

,

Garceau

D

,

Jhaveri

KD

,

Wanchoo

R

,

Bijol

V

,

Glezerman

I

, et al.

Monoclonal gammopathy-associated thrombotic microangiopathy

.

Am J Hematol

.

2019

;

94

(

10

):

E250

–

53

.

64.

Bhutani

G

,

Leung

N

,

Said

SM

,

Valeri

AM

,

Astor

BC

,

Fidler

ME

, et al.

The prevalence and clinical outcomes of microangiopathic hemolytic anemia in patients with biopsy-proven renal thrombotic microangiopathy

.

Am J Hematol

.

2022

;

97

(

11

):

E426

–

29

.

65.

Maisons

V

,

Duval

A

,

Mesnard

L

,

Frimat

M

,

Fakhouri

F

,

Grangé

S

, et al.

Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies

.

Kidney Int

.

2024

;

105

(

5

):

1100

–

12

.

66.

Lechner

K

,

Obermeier

HL

.

Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases

.

Medicine

.

2012

;

91

(

4

):

195

–

205

.

67.

Said

SM

,

Leung

N

,

Sethi

S

,

Cornell

LD

,

Fidler

ME

,

Grande

JP

, et al.

Myeloproliferative neoplasms cause glomerulopathy

.

Kidney Int

.

2011

;

80

(

7

):

753

–

9

.

68.

Nakamoto

Y

,

Imai

H

,

Yasuda

T

,

Wakui

H

,

Miura

AB

.

A spectrum of clinicopathological features of nephropathy associated with POEMS syndrome

.

Nephrol Dial Transpl

.

1999

;

14

(

10

):

2370

–

8

.

69.

Kawahara

M

,

Kanno

M

,

Matsumoto

M

,

Nakamura

S

,

Fujimura

Y

,

Ueno

S

.

Diffuse neurodeficits in intravascular lymphomatosis with ADAMTS13 inhibitor

.

Neurology

.

2004

;

63

(

9

):

1731

–

3

.

70.

Hofmeister

CC

,

Jin

M

,

Cataland

SR

,

Benson

DM

,

Wu

HM

.

TTP disease course is independent of myeloma treatment and response

.

Am J Hematol

.

2010

;

85

(

4

):

304

–

6

.

71.

Favre

GA

,

Touzot

M

,

Fremeaux-Bacchi

V

,

Hyvernat

H

,

Gueffet

JP

,

Rohrlich

PS

, et al.

Malignancy and thrombotic microangiopathy or atypical haemolytic and uraemic syndrome

.

Br J Haematol

.

2014

;

166

(

5

):

802

–

5

.

72.

Nasr

SH

,

Valeri

AM

,

Cornell

LD

,

Fidler

ME

,

Sethi

S

,

Leung

N

, et al.

Fibrillary glomerulonephritis: a report of 66 cases from a single institution

.

Clin J Am Soc Nephrol

.

2011

;

6

(

4

):

775

–

84

.

73.

Nasr

SH

,

Vrana

JA

,

Dasari

S

,

Bridoux

F

,

Fidler

ME

,

Kaaki

S

, et al.

DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis

.

Kidney Int Rep

.

2018

;

3

(

1

):

56

–

64

.

74.

Nasr

SH

,

Fogo

AB

.

New developments in the diagnosis of fibrillary glomerulonephritis

.

Kidney Int

.

2019

;

96

(

3

):

581

–

92

.

75.

Rosenstock

JL

,

Markowitz

GS

,

Valeri

AM

,

Sacchi

G

,

Appel

GB

,

D'Agati

VD

.

Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features

.

Kidney Int

.

2003

;

63

(

4

):

1450

–

61

.

76.

Alexander

MP

,

Dasari

S

,

Vrana

JA

,

Riopel

J

,

Valeri

AM

,

Markowitz

GS

, et al.

Congophilic fibrillary glomerulonephritis: a case series

.

Am J Kidney Dis

.

2018

;

72

(

3

):

325

–

36

.

77.

Amir-Ansari

B

,

O'Donnell

P

,

Nelson

SR

,

Cairns

HS

.

Fibrillary glomerulonephritis in a patient with adenocarcinoma of stomach

.

Nephrol Dial Transpl

.

1997

;

12

(

1

):

210

–

1

.

78.

Payan Schober

F

,

Jobson

MA

,

Poulton

CJ

,

Singh

HK

,

Nickeleit

V

,

Falk

RJ

, et al.

Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis

.

Am J Nephrol

.

2017

;

45

(

3

):

248

–

56

.

79.

Normand

G

,

Jolivot

A

,

Rabeyrin

M

,

Hervieu

V

,

Valette

PJ

,

Scoazec

JY

, et al.

Paraneoplastic fibrillary glomerulonephritis associated with intrahepatic cholangiocarcinoma: when diagnosis of a rare kidney disease leads to successful hepatic cancer treatment

.

Clin Res Hepatol Gastroenterol

.

2017

;

41

(

1

):

e8

–

11

.

80.

Said

SM

,

Leung

N

,

Alexander

MP

,

Cornell

LD

,

Fidler

ME

,

Grande

JP

, et al.

DNAJB9-positive monotypic fibrillary glomerulonephritis is not associated with monoclonal gammopathy in the vast majority of patients

.

Kidney Int

.

2020

;

98

(

2

):

498

–

504

.

81.

Kudose

S

,

Canetta

P

,

Andeen

NK

,

Stokes

MB

,

Batal

I

,

Markowitz

GS

, et al.

Diagnostic Approach to glomerulonephritis with fibrillar IgG deposits and light chain restriction

.

Kidney Int Rep

.

2021

;

6

(

4

):

936

–

45

.

82.

Andeen

NK

,

Troxell

ML

,

Riazy

M

,

Avasare

RS

,

Lapasia

J

,

Jefferson

JA

, et al.

Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort

.

Clin J Am Soc Nephrol

.

2019

;

14

(

12

):

1741

–

50

.

83.

Chan

S

,

Oliver

KA

,

Gray

NA

.

An association between membranoproliferative glomerulonephritis and metastatic colorectal carcinoma: a case report

.

J Med Case Rep

.

2016

;

10

:

199

.

84.

Severova

G

,

Karanfilovski

V

,

Naunovska

L

,

Suleyman

S

,

Markovska

ZS

,

Gjorgjievski

N

, et al.

Association between membranoproliferative glomerulonephritis and colorectal cancer - a case report

.

Pril Makedon Akad Nauk Umet Odd Med Nauki)

.

2024

;

45

(

2

):

31

–

6

.

85.

Usalan

C

,

Emri

S

.

Membranoproliferative glomerulonephritis associated with small cell lung carcinoma

.

Int Urol Nephrol

.

1998

;

30

(

2

):

209

–

13

.

86.

Ahmed

MS

,

Wong

CF

,

Abraham

KA

.

Membrano-proliferative glomerulonephritis associated with metastatic prostate carcinoma--should immunosuppressive therapy be considered

.

Nephrol Dial Transpl

.

2008

;

23

(

2

):

777

.

87.

Ahmed

M

,

Solangi

K

,

Abbi

R

,

Adler

S

.

Nephrotic syndrome, renal failure, and renal malignancy: an unusual tumor-associated glomerulonephritis

.

J Am Soc Nephrol

.

1997

;

8

(

5

):

848

–

52

.

88.

Reshi

AR

,

Mir

SA

,

Gangoo

AA

,

Shah

S

,

Banday

K

.

Nephrotic syndrome associated with transitional cell carcinoma of urinary bladder

.

Scand J Urol Nephrol

.

1997

;

31

(

3

):

295

–

6

.

89.

Sethi

S

,

Fervenza

FC

.

Membranoproliferative glomerulonephritis--a new look at an old entity

.

N Engl J Med

.

2012

;

366

(

12

):

1119

–

31

.

90.

Pankhurst

T

,

Savage

CO

,

Gordon

C

,

Harper

L

.

Malignancy is increased in ANCA-associated vasculitis

.

Rheumatol

.

2004

;

43

(

12

):

1532

–

5

.

91.

Tatsis

E

,

Reinhold-Keller

E

,

Steindorf

K

,

Feller

AC

,

Gross

WL

.

Wegener's granulomatosis associated with renal cell carcinoma

.

Arthritis Rheum

.

1999

;

42

(

4

):

751

–

6

.

92.

Asakura

M

,

Akimoto

T

,

Ohara

K

,

Masuda

T

,

Ono

Y

,

Saito

O

, et al.

Anti-Neutrophil cytoplasmic antibody-associated glomerulonephritis and malignancy: a case of a patient diagnosed with renal failure and pulmonary carcinoma concurrently

.

Clin Med Insights Case Rep

.

2021

;

14

:

11795476211004604

.

93.

Edgar

JD

,

Rooney

DP

,

McNamee

P

,

McNeill

TA

.

An association between ANCA positive renal disease and malignancy

.

Clin Nephrol

.

1993

;

40

(

1

):

22

–

5

.

94.

Baschinsky

DY

,

Baker

PB

,

Niemann

TH

,

Wilmer

WA

.

Pauci-immune ANCA-positive crescentic glomerulonephritis associated with metastatic adenocarcinoma of the lung

.

Am J Kidney Dis

.

2000

;

36

(

4

):

E24

.

95.

Mohammed

BT

,

Uzodi

N

,

Gotimukul

A

,

Kokebie

R

.

Case report of MPO+ ANCA vasculitis with pauci-immune GN associated with invasive ductal carcinoma of the breast

.

Curr Rheumatol Rev

.

2024

;

20

(

2

):

213

–

8

.

96.

von Vietinghoff

S

,

Schneider

W

,

Luft

FC

,

Kettritz

R

.

Crescentic glomerulonephritis and malignancy--guilty or guilt by association

.

Nephrol Dial Transpl

.

2006

;

21

(

11

):

3324

–

6

.

97.

Hruby

Z

,

Bronowicz

A

,

Rabczyński

J

,

Kopeć

W

,

Szewczyk

Z

.

A case of severe anti-neutrophil cytoplasmic antibody (ANCA)-positive crescentic glomerulonephritis and asymptomatic gastric cancer

.

Int Urol Nephrol

.

1994

;

26

(

5

):

579

–

86

.

98.

Diez-Porres

L

,

Rios-Blanco

JJ

,

Robles-Marhuenda

A

,

Gutiérrez-Molina

M

,

Gil-Aguado

A

,

Vázquez-Rodríguez

JJ

.

ANCA-associated vasculitis as paraneoplastic syndrome with colon cancer: a case report

.

Lupus

.

2005

;

14

(

8

):

632

–

4

.

99.

Au-Yang

W

,

Cheung

TY

,

Chan

HY

,

Cheuk

W

,

Cheung

CY

.

Antineutrophil cytoplasmic antibody-negative pauci-immune glomerulonephritis in a patient with Waldenstrom macroglobulinaemia

.

Nephrology

.

2024

;

29

(

11

):

767

–

71

.

100.

Faurschou

M

,

Sorensen

IJ

,

Mellemkjaer

L

,

Loft

AG

,

Thomsen

BS

,

Tvede

N

, et al.

Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients

.

J Rheumatol

.

2008

;

35

(

1

):

100

–

5

.

101.

Kalluri

R

,

Petrides

S

,

Wilson

CB

,

Tomaszewski

JE

,

Palevsky

HI

,

Grippi

MA

, et al.

Anti-alpha1(IV) collagen autoantibodies associated with lung adenocarcinoma presenting as the Goodpasture syndrome

.

Ann Intern Med

.

1996

;

124

(

7

):

651

–

3

.

102.

McGregor

C

,

Yeo

R

.

An observed association between lung cancer and the presence of anti-Glomerular Basement Membrane antibodies

.

Nephrology

.

2022

;

27

(

3

):

290

–

2

.

103.

Gao

C

,

Xie

J

,

Pan

X

,

Chen

X

.

Anti-glomerular basement membrane nephritis with bronchial carcinoma: a case report

.

J Int Med Res

.

2020

;

48

(

3

):

300060519892397

.

104.

Sugiyama

M

,

Yamada

Y

,

Nozaki

Y

,

Kinoshita

K

,

Funauchi

M

.

Anti-glomerular basement membrane glomerulonephritis after radiotherapy for early prostate cancer

.

Clin Kidney J

.

2014

;

7

(

1

):

90

–

1

.

105.

McMahon

RF

,

Lawler

W

,

O'Donoghue

DJ

,

Ballardie

FW

.

Goodpasture's syndrome in a patient with two endocrine tumours

.

Postgrad Med J

.

1989

;

65

(

766

):

582

–

6

.

106.

Maes

B

,

Vanwalleghem

J

,

Kuypers

D

,

Van Damme

B

,

Waer

M

,

Vanrenterghem

Y

.

IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy

.

Am J Kidney Dis

.

1999

;

33

(

2

):

E3

.

107.

Lachmann

HJ

,

Goodman

HJ

,

Gilbertson

JA

,

Gallimore

JR

,

Sabin

CA

,

Gillmore

JD

, et al.

Natural history and outcome in systemic AA amyloidosis

.

N Engl J Med

.

2007

;

356

(

23

):

2361

–

71

.

108.

Dictor

M

,

Hasserius

R

.

Systemic amyloidosis and non-hematologic malignancy in a large autopsy series

.

Acta Pathol Microbiol Scand A

.

1981

;

89

(

6

):

411

–

6

.

109.

Azzopardi

JG

,

Lehner

T

.

Systemic amyloidosis and malignant disease

.

J Clin Pathol

.

1966

;

19

(

6

):

539

–

48

.

110.

Bharati

J

,

Lahoud

OB

,

Jhaveri

KD

,

Izzedine

H

.

AA amyloidosis associated with cancers

.

Nephrol Dial Transpl

.

2023

;

38

(

6

):

1366

–

74

.

111.

Manwani

R

,

Wrench

D

,

Wechalekar

A

,

Lachmann

H

.

Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma

.

Br J Haematol

.

2018

;

182

(

5

):

619

.

112.

Pérez Equiza

E

,

Arguiñano

JM

,

Gastearena

J

.

Successful treatment of AA amyloidosis secondary to Hodgkin's disease with 4'-iodo-4'-deoxydoxorubicin

.

Haematologica

.

1999

;

84

(

1

):

93

–

4

.

113.

Babu

A

,

Lachmann

H

,

Pickett

T

,

Boddana

P

,

Ludeman

L

.

Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature

.

CEN Case Rep

.

2014

;

3

(

1

):

68

–

74

.

114.

Nobata

H

,

Suga

N

,

Itoh

A

,

Miura

N

,

Kitagawa

W

,

Morita

H

, et al.

Systemic AA amyloidosis in a patient with lung metastasis from renal cell carcinoma

.

Amyloid

.

2012

;

19

(

4

):

197

–

200

.

115.

Suzuki

M

,

Shinagawa

N

,

Oizumi

S

,

Fugo

K

,

Nishimura

M

.

Interleukin-6-producing undifferentiated thymic carcinoma with neuroendocrine features

.

Lung Cancer

.

2009

;

63

(

3

):

425

–

9

.

116.

d'Izarny-Gargas

T

,

Isnard

P

,

Boudhabhay

I

,

Buob

D

,

Moktefi

A

,

Linster

C

, et al.

The spectrum of glomerular and vascular kidney pathology associated with myeloproliferative neoplasms

.

Kidney Int

.

2023

;

104

(

6

):

1206

–

18

.

117.

Büttner-Herold

M

,

Sticht

C

,

Wiech

T

,

Porubsky

S

.

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

.

Histopathology

.

2021

;

78

(

5

):

738

–

48

.

118.

Lucijanic

M

,

Krecak

I

,

Kusec

R

.

Renal disease associated with chronic myeloproliferative neoplasms

.

Expert Rev Hematol

.

2022

;

15

(

2

):

93

–

6

.